Andrew Chen Archives

Subscribe · Featured · Recent · The Cold Start Problem 📘
Dear readers, I have moved to Substack and I will be writing here from now on:
In the meantime, I will leave up for posterity. Enjoy!

Cultural perspectives on failure and innovation

One of the more interesting lessons I’ve learned since joining the startup world has been the widely differing perspectives on failure and innovation. It’s a tremendous source of tension primarily built on a simple stylistic tension, which seems to occur in many different companies.

On one side, you have the free-wheeling Innovators, who instinctually move from one iteration of a project to another. Their goal is to throw up lots of ideas, see which ones stick, and build on those. Of course, this process continues indefinitely, piling failure upon failure to generate the successes. The attitude here is pretty much, "We don’t know what will succeed, so let’s do something simple, learn, and go from there." This is most commonly part of the Startup-Guy archetype, someone who is constantly on the move and shooting from the hip.

On the other side, you have the Analysis guys. Their goal is to make sure that everything’s buttoned up, that decisions are made for the right reasons, and that you have a repeatable process for success. Because most large companies have "cash cows" to protect and grow, these folks are very useful to scaling out a process in order to generate large-volume, low-risk, and high-margin products. They often have a systematic way of approaching issues, and rely more on logic and analysis than on instinct.

For me personally, I lean more towards the top (the no-holds barred Innovator) than the Analysis guy. There’s obviously lots of gray area, but I definitely tends towards one more than the other. Sometimes, when the going gets tough, I can bristle when interacting with Analysis folks. They can seem unimaginative and overly focused on process – but most importantly, their focus on making things repeatable (and big) may make something shitty into something shitty AND big. This may be what happens when you stick a bunch of these people on an unproven idea – rather than focus on verifying assumptions, testing hypotheses and coming up with new solutions, instead they want to focus on scaling up the unproven idea. Often, this leads to disasterous results. Grrr!

That said, I now realize that there’s a lot of gray area, and one is not mutually exclusive of the other.

For example, take the Big Pharma drug discovery process. The way it works is, you stick 100,000 (or whatever) possible drug candidates on one end of the "pipeline," and screen them out for all sorts of different things. Does it seem like it would work? Does it seem to attach to the right "targets?" Is it toxic to animals? Is it toxic to humans? Etc. Then at the very end, after 99,999 failures, 1 drug comes out that is approved by the FDA which makes a billion dollars a day. When rolled up, all the failure costs upwards of $800MM to produce one drug.

Now, from the outside, if the Analysis people didn’t understand this process, they’d be pretty worried. After all, they’d see drug candidate after drug candidate (99,999 in all) fail over and over. It might be depressing if you didn’t know that the entire process is only meant to produce 1 good drug, and that the payouts at the end will more than make up for all the costs.

But similarly, the pure Innovator types need to understand that they are, ultimately, making a drug. And that they probably need to make 99,999 failures to make 1 success. And that there are X number of steps to go through to get to that success rate. That way, they are hitting "innovation" metrics on the way, to ensure a deterministic march towards the billion-dollar drug. If they just focused on one thing, and morphed it quickly, they might not have enough people, drug permutations, or resources to get to the success.

So ultimately, I’ve come to believe that the startup types need to think ahead and plan, at least roughly, against the major metrics of success. For startup types, that might be a rough schedule or some ideas on how many prototypes need to be generated to be successful. Or how many users need to join in order to pronounce the user mechanics as "fully baked." So for them, if they are comfortable with micro-levels of failure, they need to keep their eye on macro-level success, and what that entails.

And for the big-time Analysis types, they need to understand how failure plays a role into their overall plan. Just because you are scaling something out, and you are hiring a big team, doesn’t mean you’ve overcome the fundamental issues in your business model. Some of that requires change, failure, and innovation to drive it forward.

The most important part is for these two groups to communicate and share a common language. Just as the drug pipeline process has been able to tie innovation with expected failure rate, dates, deliverables, and financial metrics, entrepreneurs need to be able to talk about their approach towards innovation and how that ties into ultimate success. Without it, you’ll have big companies with shaky business models, or small companies with no strategic direction.

PS. Get new updates/analysis on tech and startups

I write a high-quality, weekly newsletter covering what's happening in Silicon Valley, focused on startups, marketing, and mobile.

Views expressed in “content” (including posts, podcasts, videos) linked on this website or posted in social media and other platforms (collectively, “content distribution outlets”) are my own and are not the views of AH Capital Management, L.L.C. (“a16z”) or its respective affiliates. AH Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell -- or a solicitation of an offer to buy -- any securities, and may not be used or relied upon in evaluating the merits of any investment.

The content should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources. While taken from sources believed to be reliable, I have not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. The content speaks only as of the date indicated.

Under no circumstances should any posts or other information provided on this website -- or on associated content distribution outlets -- be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles -- which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters. There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available at Excluded from this list are investments for which the issuer has not provided permission for a16z to disclose publicly as well as unannounced investments in publicly traded digital assets. Past results of Andreessen Horowitz’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Please see for additional important information.